文献速递神经免疫认知障碍与痴呆

视网膜结构、鞘内免疫与多发性硬化临床病程的关联

Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis.
PubMed 文献 · JAMA Neurol · 2017-01-01

该观察性队列研究纳入312例复发缓解型多发性硬化患者,分两个独立队列,探讨视网膜层体积与脑脊液免疫细胞亚群及免疫球蛋白指数的相关性,并分析其与残疾恶化的关系。结果显示低GCIPL体积与鞘内B细胞频率升高及IgG合成增加相关,且为残疾恶化的独立危险因素;INL体积与MRI病灶活动相关。

要点

  • 低GCIPL体积与鞘内B细胞免疫相关,是残疾恶化的独立危险因素。
  • GCIPL<1.99 mm3者随访期残疾恶化风险为6.4倍(95%CI 1.7-24.2)。
  • INL体积与T2病灶负荷增加及钆增强病灶数相关,反映MRI活动。

核心结论

  • 视网膜层反映多发性硬化不同方面的疾病活动,GCIPL丢失与鞘内B细胞免疫相关并为残疾恶化独立危险因素,高INL体积与脑实质MRI活动相关。
  • 视网膜光学相干断层扫描或可支持多发性硬化患者不同治疗方案的分层。

研究设计与样本

  • 观察性队列研究,纳入312例复发缓解型多发性硬化患者,分2个独立队列:队列1为72例短病程患者,队列2为240例较长病程患者。
  • 患者于2013年4月15日至2015年11月11日在德国一家大学医院接受治疗。

主要发现

  • 队列1中低GCIPL体积与鞘内B细胞频率升高(中位数1.96%,IQR 1.45%-4.20%)及鞘内IgG合成(脑脊液/血清IgG指数中位数0.78,IQR 0.53-1.07)相关。
  • INL体积与鞘内CD56bright自然杀伤细胞频率相关(r=0.28;P=.007)。
  • GCIPL<1.99 mm3者随访期残疾恶化风险为6.4倍(95%CI 1.7-24.2;P=.007),队列2再现该结果(HR 2.4;95%CI 1.2-4.8;P=.02)。
  • 两队列中INL体积均与前瞻性T2病灶负荷增加及钆增强病灶数相关。

关键数值与推荐

  • 队列1:72例,女50例(69.4%)、男22例(30.6%),中位年龄31.0岁(IQR 26.3-38.3),中位病程1.0个月(IQR 1.0-2.0)。
  • 队列2:240例,女162例(67.5%)、男78例(32.5%),中位年龄34.0岁(IQR 29.0-42.0),中位病程36.0个月(IQR 21.0-60.0)。
  • 总体:312例,女212例(67.9%)、男100例(32.1%),中位年龄34.0岁(IQR 28.0-42.0)。

临床怎么用

  • 可考虑用视网膜OCT测量的GCIPL体积辅助评估多发性硬化残疾恶化风险。
  • GCIPL体积结合鞘内B细胞频率等指标或有助于患者治疗方案分层。
  • INL体积变化可提示脑实质MRI病灶活动,作为随访参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Biomarkers to estimate long-term outcomes in patients with multiple sclerosis (MS) and to assign patients to individual treatment regimens are urgently needed. OBJECTIVE: To assess whether retinal layer volumes are correlated with immune cell subsets and immunoglobulin indices in the cerebrospinal fluid and whether retinal layer volumes alone or in combination with intrathecal variables are associated with worsening of disease in patients with relapsing-remitting MS. DESIGN, SETTING, AND PARTICIPANTS: This observational cohort study included 312 patients with relapsing-remitting MS in 2 independent cohorts (72 patients with short disease duration [cohort 1] and 240 patients with longer disease duration [cohort 2]) treated at a single German university hospital from April 15, 2013, through November 11, 2015. MAIN OUTCOMES AND MEASURES: The common ganglion cell and inner plexiform layer (GCIPL) and inner nuclear layer (INL) volumes were tested for association with the immunoglobulin indices and the frequencies of immune cells in the cerebrospinal fluid (including B cells, T cells, and natural killer cells) (cohort 1). Volumes of GCIPL alone (cohorts 1 and 2) or GCIPL corrected for intrathecal B-cell frequencies (cohort 1) were tested for their association with worsening disability. RESULTS: A total of 312 patients (212 women [67.9%] and 100 men [32.1%]; median age, 34.0 years [interquartile range (IQR), 28.0-42.0 years]) were available for analysis. In cohort 1 (50 women [69.4%] and 22 men [30.6%]; median age, 31.0 years [IQR, 26.3-38.3 years]), with short disease durations (median, 1.0 months [IQR, 1.0-2.0 months]), low GCIPL volumes were associated with increased intrathecal B-cell frequencies (median, 1.96% [IQR, 1.45%-4.20%]) and intrathecal IgG synthesis (median cerebrospinal fluid/serum IgG index, 0.78 [IQR, 0.53-1.07]). The INL volumes correlated with the frequencies of intrathecal CD56bright natural killer cells (r = 0.28; P = .007). Individuals with low GCIPL volumes (<1.99 mm3) had a 6.4-fold risk for worsening disability during follow-up compared with patients with higher GCIPL values (95% CI, 1.7-24.2; P = .007). This finding was reproduced in cohort 2 (162 women [67.5%] and 78 men [32.5%]; median age, 34.0 years [IQR, 29.0-42.0 years]) consisting of patients with longer disease durations (median, 36.0 months [IQR, 21.0-60.0 months]) (hazard ratio, 2.4; 95% CI, 1.2-4.8; P = .02). In both cohorts, INL volumes correlated with the prospective increase in T2 lesion load and the number of gadolinium-enhancing lesions. CONCLUSIONS AND RELEVANCE: Retinal layers reflect different aspects of disease activity during MS. Loss of GCIPL is associated with intrathecal B-cell immunity and constitutes an independent risk factor for worsening disability, whereas high INL volumes are associated with activity on magnetic resonance imaging in the brain parenchyma. Thus, retinal optical coherence tomography might be a means to support stratification of patients with MS for different therapeutic regimens.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Knier B, Leppenetier G, Wetzlmair C, et al. Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis. JAMA Neurol. 2017. PMID: 28460032. doi:10.1001/jamaneurol.2017.0377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。